Barry Hall
Overview
Explore the profile of Barry Hall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farrell R, ORegan R, ONeill E, Bowens G, Maclellan A, Gileece A, et al.
Ir J Med Sci
. 2020 Nov;
190(3):893-903.
PMID: 33141353
Introduction: Our hospital found itself at the epicentre of the Irish COVID-19 pandemic. We describe the organisational challenges faced in managing the surge and identified risk factors for mortality and...
2.
Burr N, Hall B, Hamlin P, Selinger C, Ford A, OConnor A
J Crohns Colitis
. 2018 Dec;
13(6):693-701.
PMID: 30561586
Background And Aims: Surgery is an important treatment for Crohn's disease [CD], but recurrence occurs in up to 80% of individuals post-operatively. The efficacy of several drugs to prevent post-operative...
3.
Awosoga O, Pijl E, Hagen B, Hall B, Sajobi T, Spenceley S
J Adv Nurs
. 2018 Jul;
74(11):2685-2700.
PMID: 30019353
Aims: To report on the development and validation of the Moral Distress in Dementia Care Survey instrument. Background: Despite growing awareness of moral distress among nurses, little is known about...
4.
Selinger C, Hall B
Pol Arch Intern Med
. 2017 Nov;
127(10):650-651.
PMID: 29162787
No abstract available.
5.
Tighe D, Hall B, Jeyarajah S, Smith S, Breslin N, Ryan B, et al.
Inflamm Bowel Dis
. 2017 May;
23(7):1154-1159.
PMID: 28486256
Background: Loss of response (LOR) is a big concern for anti-TNFa therapies in inflammatory bowel disease. Immunomonitoring may be useful to optimize response rates and overcome secondary LOR. Methods: This...
6.
Pijl-Zieber E, Awosoga O, Spenceley S, Hagen B, Hall B, Lapins J
Dementia (London)
. 2016 Apr;
17(3):315-336.
PMID: 27094602
Objective Moral distress is increasingly being recognized as a concern for health care professionals. The purpose of this study was to explore the nature and prevalence of moral distress among...
7.
Holleran G, Hall B, Breslin N, McNamara D
United European Gastroenterol J
. 2016 Mar;
4(1):70-6.
PMID: 26966525
Introduction: Small bowel angiodysplasias account for over 50% of causes of small bowel bleeding and carry a worse prognosis than lesions located elsewhere in the gastrointestinal tract. Re-bleeding rates are...
8.
Spenceley S, Witcher C, Hagen B, Hall B, Kardolus-Wilson A
Dementia (London)
. 2015 Dec;
16(7):815-834.
PMID: 26631822
The World Health Organization estimates the number of people living with dementia at approximately 35.6 million; they project a doubling of this number by 2030 and tripling by 2050. Although...
9.
Hall B, Holleran G, McNamara D
World J Gastrointest Endosc
. 2015 Nov;
7(16):1230-2.
PMID: 26566430
A recent paper by Boal Carvalho et al demonstrates the potential of PillCam COLON 2(©) (PCC2) as a pan-enteric investigation in Crohn's disease (CD). Our own prospective data in patients...
10.
Holleran G, Hall B, Zgaga L, Breslin N, McNamara D
Scand J Gastroenterol
. 2015 Nov;
51(4):393-9.
PMID: 26540240
Background: Small bowel angiodysplasias (SBA) account for 50% of obscure gastrointestinal bleeding. Lesions bleed recurrently and current treatments are relatively ineffective at reducing re-bleeding. Little is known about the natural...